Futura Medical PLC
20 September 2004
Press Release 20 September 2004
Futura Medical plc
('Futura' or 'the Company')
Notice of Interim Results - Monday 27 September 2004
Futura Medical plc, the pharmaceutical and medical device group that develops
innovative products for the sexual healthcare market, will announce its interim
results for the six months ended 31 July 2004 on Monday 27 September 2004.
- Ends -
For further information:
Futura Medical plc
James Barder, Chief Executive Officer +44 (01483) 685670
Anthony Clayden, Finance Director
james.barder@futuramedical.co.uk www.futuramedical.co.uk
anthony.clayden@futuramedical.co.uk
Media enquiries:
Abchurch
Peter Curtain / Alex Tweed Tel: +44 (0) 20 7398 7700
alex.tweed@abchurch-group.com www.abchurch-group.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.